JPM26: Matrix-M Technology is central to Novavax's strategy [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
From a financial standpoint, Novavax ended 2025 with cash and receivables of approximately $920m, providing runway into 2028. Other achievements in 2025 included milestone payments, the development and advancement of pipeline programs, and increased market shares for already licensed products. The overarching theme relayed by Jacobs was the success of Novavax's Matrix-M technology and the value of its partnerships. Novavax's Matrix-M is a proprietary vaccine adjuvant that has been shown to enhance immune response and vaccine effectiveness. Matrix-M contains saponins from the bark of the soapbark tree and works by activating both the body's innate and adaptive immune systems. Matrix-M is used in Novavax's Covid-19 vaccine, Nuvaxovid, which is marketed by Sanofi and Takeda, as well as the University of Oxford and the Serum Institute of India's malaria vaccine, R21/Matrix-M. In 2025, Nuvaxovid's US Biologics License Application (BLA) was approved, and in 2026, the vaccine will have a
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- 85 years of bold discovery: Texas Biomed marks milestone anniversary [Yahoo! Finance]Yahoo! Finance
- Novavax to Participate in the 44th Annual J.P. Morgan Healthcare ConferencePR Newswire
- Is Novavax (NVAX) Mispriced After Recent Share Rebound And DCF Upside Projection [Yahoo! Finance]Yahoo! Finance
- Novavax (NVAX) Stock Trades Up, Here Is Why [Yahoo! Finance]Yahoo! Finance
- Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 11/6/25 - Miss
NVAX
Sec Filings
- 1/12/26 - Form 8-K
- 12/15/25 - Form 4
- 11/12/25 - Form SCHEDULE
- NVAX's page on the SEC website